ReviewTransfusion2026

Enabling community-based autologous adaptive immune cellular therapy manufactured at the point of care: A narrative review of global regulatory frameworks, affordability, and implementation strategy of a novel integrated facility and digital platform in the United States.

R Brent Dixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.